The prevalence and impact of migraine and severe headache in the United States: Updated age, sex, and socioeconomic‐specific estimates from government health surveys

Accurate, up‐to‐date estimates of the burden of migraine and severe headache are important for evidence‐based decision‐making about workforce needs and the distribution of health resources. We used data from US government health surveys to report the prevalence, trends, and impact of this condition by age, sex, and poverty status.

• Publication year

  2020

• Venue

  Headache

• Publication date

  2020-12-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/head.14024PMID 33349955
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Workforce Gap Analysis in the Field of Headache Medicine in the United States

  2020cited by this paper
• COVID-19 exacerbating inequalities in the US

  2020cited by this paper
• Inequality in the impact of the coronavirus shock: Evidence from real time surveys

  2020cited by this paper
• Health Behaviors and Social Determinants of Migraine in a Canadian Population‐Based Sample of Adults Aged 45‐85 Years: Findings From the CLSA

  2019cited by this paper
• Contribution of specific diseases and injuries to changes in health adjusted life expectancy in 187 countries from 1990 to 2013: retrospective observational study

  2019cited by this paper
• Calcitonin Gene-Related Peptide Monoclonal Antibody Treatments for Migraine

  2019cited by this paper
• Who Should Try New Antibody Treatments for Migraine?

  2018cited by this paper
• The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies

  2018cited by this paper
• Examining the Relationship between Economic Hardship and Child Maltreatment Using Data from the Ontario Incidence Study of Reported Child Abuse and Neglect-2013 (OIS-2013)

  2017cited by this paper
• The Prevalence and Burden of Migraine and Severe Headache in the United States: Updated Statistics From Government Health Surveillance Studies

  2015cited by this paper
• The Prevalence, Burden, and Treatment of Severe, Frequent, and Migraine Headaches in US Minority Populations: Statistics From National Survey Studies

  2015cited by this paper
• Patterns of Use and Health Expenses Associated With Triptans Among Adults With Migraines

  2015cited by this paper
• Recalled maltreatment, migraine, and tension-type headache

  2015cited by this paper
• Migraine prevalence, socioeconomic status, and social causation

  2013cited by this paper
• The Prevalence, Impact, and Treatment of Migraine and Severe Headaches in the United States: A Review of Statistics From National Surveillance Studies

  2013cited by this paper
• The Effect of Migraine Headache on Educational Attainment

  2011cited by this paper
• Adverse Childhood Experiences and Frequent Headaches in Adults

  2010cited by this paper
• Impact of insurance status on migraine care in the United States

  2010cited by this paper
• Low Income and Education Levels May Cause Medication Overuse and Chronicity in Migraine Patients

  2005cited by this paper
• International classification of diseases: ninth revision.

  1978cited by this paper

• Unmasking COVID-19 Headaches in Healthcare Professionals: Phenotypic Continuity Across Infection, Reinfection, Vaccination and Post-COVID

  2026influential citation
• Prevalence of Intracranial and Cervical Artery Abnormalities in Patients with Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders Presenting to an Academic Headache Clinic.

  2026cites this paper
• Headache care around the world: a review of access, equity, and system-level solutions.

  2026cites this paper
• Sexual dysfunction in women with migraines: a systematic review

  2026influential citation
• Migraine as a primary care-sensitive condition: Building pathways to accessible care

  2026cites this paper
• Sex differences in self-reported symptoms and comorbidities associated with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders: A retrospective study

  2026cites this paper
• Shared genetic structure between COVID-19 and migraine: insights from large-scale genome-wide cross-trait analysis.

  2026cites this paper
• The personal relevance of digital health technologies for self-management of chronic conditions: instrument development and validation

  2026cites this paper
• Geographic and rural health care resource gaps in orofacial pain provider distribution across the United States.

  2026cites this paper
• Association of diet quality, dietary acid load and antioxidant index with migraine severity, disability, and duration: a cross-sectional study.

  2026cites this paper
• The optimisation of migraine prevention: an urgent need.

  2026cites this paper
• Frequency of Migraine Recorded in Primary Care and Hospital Records in Aotearoa New Zealand: a Cross-Sectional Study

  2026cites this paper
• Practice recommendations for contextualizing explanations of headache pain within a biopsychosocial model.

  2025cites this paper
• Socioeconomic Factors Associated With Migraine Medication Prescription at a Tertiary Headache Center: A Retrospective Cohort Analysis.

  2025cites this paper
• Risk of depression and suicide in adults with pre-existing primary headaches.

  2025cites this paper
• Education and Social Life: The Impact of Headache on Participation in Children and Adolescents Attending a Headache Clinic-A Case-Control Study.

  2025cites this paper
• Modulating the Gut Microbiota to Target Neuroinflammation, Cognition and Mood: A Systematic Review of Human Studies with Relevance to Fibromyalgia

  2025cites this paper
• Health Care Utilization Patterns Associated with eConsults for Headache: Insights from an Urban Academic Medical Center

  2025cites this paper
• Exploring the Link Between Inflammatory Biomarkers (SII, SIRI, PLR, NLR, LMR) and Migraine in Young and Early Middle‐Aged US Adults: Evidence From NHANES 1999–2004 and Machine Learning Models

  2025cites this paper
• The burden of migraine and tension-type headache in Asia from 1990 to 2021

  2025cites this paper
• Treatment Patterns and Healthcare Resource Utilization by Gender and Migraine Frequency in Adult Patients Receiving Galcanezumab Versus Standard of Care Preventive Medications Over 24 months: A United States Retrospective Claims Study

  2025cites this paper
• Anatomical and physiological contributions of nasal turbinate vessels and lymphatics to the pathogenesis of nasal congestion in recurrent headaches: a pilot study

  2025cites this paper
• Comprehensive study on headache in otorhinolaryngology

  2025cites this paper
• Sex-Specific Difference in Health-Related Altitude-Effects and Their Prevention by Acetazolamide. Data from a Randomized Controlled Trial

  2025cites this paper
• Gepantes: Aspectos Clave de Una Potente Opción Terapéutica y Consideraciones en el Contexto Latinoamericano

  2025cites this paper
• Practice advisory for intravenous management of headache disorders in hospitalized patients: a review of the evidence and consensus recommendations

  2025cites this paper
• Invisible burdens: Gender-specific associations between migraine and work–family conflict

  2025cites this paper
• Exploring the tangible and intangible cost dimensions in global noncommunicable disease research using systematic content analysis

  2025cites this paper
• Effect and Safety of Phytosomal Curcumin Supplementation on Migraine Patients: A Randomized, Double-Blind and Placebo-Controlled Trial

  2025cites this paper
• Three years of remote electrical neuromodulation (REN) acute treatment for migraine shows consistent effectiveness and no tachyphylaxis phenomenon

  2025cites this paper
• Interaction between dietary selenium intake and age on severe headache or migraine in the United States: a population-based study

  2025cites this paper
• Assessment of serum oxidative stress parameters in migraine patients

  2025cites this paper
• Enhancement of the endocannabinoid system through monoacylglycerol lipase inhibition relieves migraine-associated pain in mice

  2025cites this paper
• Home Environment as a Therapeutic Target for Prevention and Treatment of Chronic Diseases: Delivering Restorative Living Spaces, Patient Education and Self-Care by Bridging Biophilic Design, E-Commerce and Digital Health Technologies

  2025influential citation
• Trends in the Burden of Headache Disorders in Europe, 1990–2021: A Systematic Analysis from the Global Burden of Disease Study 2021

  2025cites this paper
• NeuroDiscovery AI database: Comprehensive EHR dataset for Neurology

  2025influential citation
• The Association Between Age of First Exposure to American Football at a Young Age and Later-Life Health Issues in Healthy, Community-Dwelling Adults

  2025cites this paper
• Prevention of Episodic Migraine Headache Using Pharmacologic Treatments in Outpatient Settings: A Clinical Guideline From the American College of Physicians

  2025cites this paper
• Fear of COVID-19, physical activity practice and chronic pain symptoms in the postvaccination period.

  2025cites this paper
• Descriptive epidemiological study of migraine in three emergency departments of the public health network of Chile

  2025cites this paper
• Patient Preferences for Episodic Migraine Medications: A Discrete Choice Experiment of Self-Injectable Versus Oral Treatments Targeting Calcitonin Gene-Related Peptide Pathway

  2025cites this paper
• Migraine and sleep apnea, insomnia, and sleep patterns in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

  2025cites this paper
• Assessment of sleep patterns in migraine sufferers using the Epworth Sleepiness Scale

  2025cites this paper
• Prevalence of Migraine and Other Types of Primary Headache in China: A Systematic Review and Meta-Analysis

  2025cites this paper
• Saudi clinical practice guidelines for the treatment and prevention of migraine headache

  2025cites this paper
• Health care resource utilization and direct costs incurred over 12 months by patients with migraine initiating self-injectable calcitonin gene-related peptide monoclonal antibodies: A US real-world study.

  2025cites this paper
• L-shaped relationship between dietary vitamin E intake and migraine in adults: a cross-sectional analysis of NHANES 1999–2004

  2025influential citation
• Short-term associations between ambient air pollution and emergency department visits for Parkinson disease, multiple sclerosis, migraine, and seizure in California, 2005–2018

  2025influential citation
• Real-world effectiveness of eptinezumab in chronic migraine—increase in good days in three subgroups: psychiatric comorbidities, prior subcutaneous anti-calcitonin gene-related peptide therapy, and migraine-associated brain fog

  2025cites this paper
• Can smartwatches predict migraines? Using machine learning (ML) with wearable-derived nocturnal autonomic nervous system (ANS) and sleep metrics for headache prediction

  2025cites this paper
• The Global Prevalence of Sexual Dysfunction in Migraine Patients: A Systematic Review and Meta-Analysis

  2025cites this paper
• Diagnosis of subarachnoid haemorrhage: Systematic evaluation of CT head diagnostic accuracy and comparison with the 2022 NICE guidelines

  2025cites this paper
• The effect of treatment onset time on acute efficacy in migraine patients treating with remote electrical neuromodulation (REN)

  2025cites this paper
• Impact of Barometric Pressure Changes on the Severity, Frequency, and Duration of Migraine Attacks: A Systematic Review of the Literature

  2025cites this paper
• Evaluating brain mechanisms of combined vagus nerve stimulation and mindfulness training for migraine: A randomized 2 × 2 factorial clinical trial protocol.

  2025cites this paper
• Pharmacologic Treatments of Acute Episodic Migraine Headache in Outpatient Settings: A Clinical Guideline From the American College of Physicians

  2025cites this paper
• Impact of migraine on productivity and efficiency among adult population in India: a scoping review

  2025cites this paper
• Migraine-Related Burden, Treatment Interventions, and Healthcare Experiences by Race and Ethnicity: Results of the Migraine Report Card Survey.

  2025cites this paper
• Migraine in the workplace: Work productivity impact in a large US‐based healthcare system using a cross‐sectional employee survey

  2025cites this paper
• Brain Hsp90 Inhibition Mitigates Facial Allodynia in a Rat Model of CSD Headache and Upregulates Endocannabinoid Signaling in the PAG

  2025cites this paper
• Behavioral Treatment Strategies for Headache Management.

  2025cites this paper
• A Discrete-Choice Experiment Assessing the Patient Preferences and Real-World Experiences of Patients with Migraine in Japan

  2024cites this paper
• Household income is associated with attack frequency, but not with the prevalence of headache: an analysis of self-reported headache in the general population in Germany

  2024cites this paper
• Evaluation of rimegepant utilization patterns and patient characteristics among new users: a United States administrative claims-based study

  2024cites this paper
• Comparison of clinical pharmacist practitioners’ headache care roles across clinical contexts within the Veterans Health Administration: Optimizing pharmacist integration

  2024cites this paper
• Can migraine be triggered by unemployment in France? A Bi-Probit/Multinomial probit approach

  2024cites this paper
• Manejo de la migraña en los servicios de urgencias hospitalarios: estudio observacional retrospectivo realizado en el Hospital Universitario Virgen del Rocío

  2024cites this paper
• A New Antibody Treatment for Migraine.

  2024cites this paper
• Changes in use of acute and preventive medications for migraine after erenumab initiation over 12 months: A United States retrospective cohort study

  2024cites this paper
• Investigation of the Prevalence of Primary Headaches and the Factors Affecting the Acceptance of Perceived Pain in Elderly Individuals with Headaches

  2024cites this paper
• Sex and age-related patterns in pediatric primary headaches: observations from an outpatient headache clinic

  2024cites this paper
• The P300 component of the auditory event-related potential in adult psychiatric and neurologic disorders: a narrative review of clinical and experimental evidence.

  2024cites this paper
• Treatment patterns of patients with migraine eligible for anti-CGRP pathway monoclonal antibodies

  2024cites this paper
• Changes in Use of Migraine Medications, Healthcare Resource Utilization, and Associated Direct Costs Over 12 Months Following Initiation of Erenumab: A US Retrospective Real-World Analysis

  2024cites this paper
• Characterization of rimegepant drug–drug interactions using the cytochrome P450 probe drugs, itraconazole, rifampin, fluconazole, and midazolam

  2024cites this paper
• Documentation of International Classification of Headache Disorders Criteria in Patient Medical Records: A Retrospective Cohort Analysis

  2024cites this paper
• Healthcare resource use and costs associated with the misdiagnosis of migraine

  2024cites this paper
• Association between the Composite Dietary Antioxidant Index and severe headache or migraine: results from the National Health and Nutrition Examination Survey

  2024cites this paper
• Role of Phytocompounds for Effective Management of Migraine: Current and Future Prospectives.

  2024cites this paper
• Clinical factors associated with day‐to‐day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data

  2024cites this paper
• Migraine in adults

  2024cites this paper
• Understanding migraine in Saudi society: An assessment of public knowledge and attitudes: A cross-sectional study

  2024cites this paper
• The impact of updates in headache quality measures on adherence to best practices in a neurology resident clinic: A quality improvement study

  2024cites this paper
• Concentration‐QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval

  2024cites this paper
• The Role of the Autonomic Nervous System in Epilepsy and Migraine: A Narrative Review.

  2024cites this paper
• Auricular Therapy for Migraine

  2024cites this paper
• Prevalence and burden of migraine in the United States: A systematic review

  2024cites this paper
• Real-world effectiveness and satisfaction with intravenous eptinezumab treatment in patients with chronic migraine: REVIEW, an observational, multi-site, US-based study

  2024cites this paper
• Unani insights on migraine: psychological and holistic care

  2024cites this paper
• Blood Pressure, Cardiometabolic Traits, and Cardiovascular Events in Women With Uterine Fibroids: A Genetic Correlation and Mendelian Randomization Study

  2024cites this paper
• Safety and efficacy of galcanezumab in chronic and episodic migraine patients: a systematic review and meta-analysis of randomized controlled trials

  2024influential citation
• Pharmacogenomic study—A pilot study of the effect of pharmacogenomic phenotypes on the adequate dosing of verapamil for migraine prevention

  2024cites this paper
• Migraine epidemiology in collegiate student‐athletes: Findings from the Concussion Assessment, Research, and Education (CARE) Consortium

  2024cites this paper
• Assessing the Relationship between Obesity and Trigger Point-specific Outcomes after Headache Surgery

  2024cites this paper
• Underrepresented and Underserved Populations in Neurological Research

  2024cites this paper
• Migraine Prevalence, Environmental Risk, and Comorbidities in Men and Women Veterans

  2024cites this paper
• The Chronic Headache Self‐Efficacy Scale: Development and assessment of measurement properties

  2024cites this paper
• Quality of life in women with migraine: a systematic review

  2024cites this paper
• Assessment of Relationship Between Dietary Factors, Socioeconomic Factors, Behavioral Factors, Physical Measurement, and Risk of Migraine

  2024cites this paper
• Cost-Effectiveness Evaluation of Oral CGRP Antagonists, Atogepant and Rimegepant, for the Preventative Treatment of Episodic Migraine: Results from a US Societal Perspective Model

  2024cites this paper